AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6107407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) 3000 units (75 micrograms) daily
Number of subjects: 7
Study 6107407 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxycholecalciferol 1 microgram daily
Number of subjects: 7
Study 31237435 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency coronary angiography (CAG) performed within 2 hours
Number of subjects: 166
Study 31237435 — intervention group
Group type: COMPARATOR
Intervention: Deferred coronary angiography (CAG) performed before discharge
Number of subjects: 166
Study 31237435 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups receive routine care in the intensive cardiac care unit, including therapeutic hypothermia
Number of subjects: 166
Study 31255307 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency WBV (30 Hz)
Number of subjects: 24
Study 31255307 — intervention group
Group type: COMPARATOR
Intervention: High-frequency WBV (50 Hz)
Number of subjects: 24
Study 28152124 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal injection of 0.1 mL of a gene therapy solution containing 1 × 10^11 viral particles
Number of subjects: 5
Study 28152124 — intervention group
Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 5
Study 24796864 — intervention group
Group type: EXPERIMENTAL
Intervention: diet
Number of subjects: 439
Study 24796864 — intervention group
Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 439
Study 24796864 — intervention group
Group type: EXPERIMENTAL
Intervention: diet + exercise
Number of subjects: 439
Study 24796864 — intervention group
Group type: COMPARATOR
Intervention: no-lifestyle-change control
Number of subjects: 439
Study 23172847 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle treatment programme with physiotherapist involvement
Number of subjects: 64
Study 23172847 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle treatment programme without physiotherapist involvement
Number of subjects: 64
Study 23172847 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention comparison group of children with obesity
Number of subjects: 64
Study 21216670 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg once per day, orally) for 3 months starting 5-10 days after stroke onset
Number of subjects: 118
Study 21216670 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 months starting 5-10 days after stroke onset
Number of subjects: 118
Study 19381809 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho‐educational program (eight sessions)
Number of subjects: 169
Study 19381809 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 169
Study 17382151 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine ointment combined with tramadol drops 1 mg/kg per os 40 minutes before the procedure (group 2)
Number of subjects: 77
Study 17382151 — intervention group
Group type: COMPARATOR
Intervention: 5% lidocaine ointment 5 mL per rectum 10 minutes before the procedure (group 1)
Number of subjects: 77
Study 15245526 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet wrap therapy (WWT) with 1% hydrocortisone (HC) applied once in the morning for 2 weeks, wet wraps twice daily for week 1, and only at night for week 2
Number of subjects: 19
Study 15245526 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone (HC) applied twice daily without wet wraps
Number of subjects: 19
Study 11753990 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT), mean total dose 65 grays (Gy; 62.3-70 Gy)
Number of subjects: 108
Study 11753990 — intervention group
Group type: COMPARATOR
Intervention: Deferred treatment (DT)
Number of subjects: 108
Study 11753990 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched, n=68)
Number of subjects: 108
Study 9669469 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (IVMP) pulse therapy (2 g)
Number of subjects: 20
Study 9669469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7838445 — intervention group
Group type: EXPERIMENTAL
Intervention: Min-Max method
Number of subjects: 0
Study 7838445 — intervention group
Group type: COMPARATOR
Intervention: Average method
Number of subjects: 0
Study 3154322 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 0
Study 3154322 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic versus single digoxin dosing
Number of subjects: 0
Study 3154322 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for future studies
Number of subjects: 0
Study 29471557 — intervention group
Group type: EXPERIMENTAL
Intervention: Completely metal-free ceramic system (matrix of aluminum and zirconium oxide)
Number of subjects: 80
Study 29471557 — intervention group
Group type: COMPARATOR
Intervention: Anatomically identical metallic knee system (cobalt-chromium alloy)
Number of subjects: 80
Study 29471557 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (metal-free ceramic and metallic knee system)
Number of subjects: 80
Study 28376725 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition training for midlevel providers (MLPs)
Number of subjects: 776
Study 26092311 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine D2-receptor antagonist sulpiride (400 mg)
Number of subjects: 40
Study 26092311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 22752050 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 150-mg once a month
Number of subjects: 1292
Study 22752050 — intervention group
Group type: COMPARATOR
Intervention: Risedronate 5-mg daily
Number of subjects: 1292
Study 20964572 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sunflower oleodistillate (SO) cream applied twice a day
Number of subjects: 80
Study 20964572 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyro-propionate 1 mg/g applied twice a day
Number of subjects: 80
Study 18164562 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta‐estradiol 1mg plus norethisterone acetate 0.5 mg (E(2)/NETA)
Number of subjects: 88
Study 18164562 — intervention group
Group type: EXPERIMENTAL
Intervention: raloxifene HCl 60 mg
Number of subjects: 88
Study 16418760 — intervention group
Group type: EXPERIMENTAL
Intervention: Gx (500 mg capsules containing 6 mg synephrine, 150 mg caffeine, and 150 mg catechin polyphenols)
Number of subjects: 20
Study 16418760 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 20
Study 16418760 — intervention group
Group type: EXPERIMENTAL
Intervention: Gx
Number of subjects: 20
Study 14593356 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (500 mg BID loading dose for 2 days and 250 mg BID for subsequent 5 days)
Number of subjects: 37
Study 14593356 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose and 75 mg/day for subsequent 6 days)
Number of subjects: 37
Study 14593356 — intervention group
Group type: COMPARATOR
Intervention: Control (no ticlopidine)
Number of subjects: 37
Study 14593356 — intervention group
Group type: COMPARATOR
Intervention: Control (no clopidogrel)
Number of subjects: 37
Study 11001866 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day prednisolone
Number of subjects: 21
Study 11001866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 8620255 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention program (self-instructional module, audiotape, health consultation with physician/nurse, follow-up consultation with peer health model)
Number of subjects: 104
Study 1727109 — intervention group
Group type: EXPERIMENTAL
Intervention: 2400 cGy cranial irradiation
Number of subjects: 35
Study 1727109 — intervention group
Group type: EXPERIMENTAL
Intervention: 1800 cGy cranial irradiation
Number of subjects: 35
Study 1727109 — intervention group
Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 35
Study 6389477 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxacin (400 mg twice daily for 14 days)
Number of subjects: 24
Study 6389477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29982430 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious sedation with midazolam and fentanyl
Number of subjects: 103
Study 29982430 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 103
Study 28734105 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Nerve Neural Mobilization (MNNM)
Number of subjects: 60
Study 28734105 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control Group (WLCG)
Number of subjects: 60
Study 26672923 — intervention group
Group type: EXPERIMENTAL
Intervention: Open lung approach
Number of subjects: 200
Study 26672923 — intervention group
Group type: COMPARATOR
Intervention: Acute Respiratory Distress Syndrome network protocol
Number of subjects: 200
Study 25363108 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on precede-proceed model
Number of subjects: 128
Study 25363108 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 128
Study 22609079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of intersphincteric fistula tract (LIFT)
Number of subjects: 39
Study 22609079 — intervention group
Group type: COMPARATOR
Intervention: Anorectal advancement flap (ARAF)
Number of subjects: 39
Study 22609079 — intervention group
Group type: EXPERIMENTAL
Intervention: LIFT
Number of subjects: 39
Study 22609079 — intervention group
Group type: COMPARATOR
Intervention: ARAF
Number of subjects: 39
Study 20956826 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 93
Study 20956826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 20956826 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 93
Study 17431063 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of diazepam
Number of subjects: 20
Study 17431063 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 15938034 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan
Number of subjects: 0
Study 15938034 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study 12131781 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide 300 mg/d
Number of subjects: 207
Study 12131781 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide 600 mg/d
Number of subjects: 207
Study 12131781 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide 1200 mg/d
Number of subjects: 207
Study 12131781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 10220845 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy rehabilitation (1 h, twice weekly) with emphasis on balance training
Number of subjects: 92
Study 10220845 — intervention group
Group type: COMPARATOR
Intervention: Standard information regarding early ankle mobilization (Control group)
Number of subjects: 92
Study 10220845 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical therapy rehabilitation
Number of subjects: 92
Study 10220845 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study 7823670 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-washing intervention program plus mass topical antibiotic treatment
Number of subjects: 1417
Study 7823670 — intervention group
Group type: COMPARATOR
Intervention: Mass topical antibiotic treatment only (Control)
Number of subjects: 1417
Study 7823670 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean face at two or more follow-up visits
Number of subjects: 1417
Study 2352788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate for 10 weeks
Number of subjects: 36
Study 2352788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 484262 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 19
Study 484262 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 19
Study 31309627 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical product containing 3 antioxidants (pre‐tocopheryl®, retinaldehyde, glycylglycine ole‐amide)
Number of subjects: 20
Study 31309627 — intervention group
Group type: COMPARATOR
Intervention: Positive antioxidant control cream
Number of subjects: 20
Study 31309627 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 20
Study 28412590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab + FOLFIRI
Number of subjects: 0
Study 28412590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab treatment for CEA ≤10 subgroup
Number of subjects: 0
Study 28412590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab treatment for CEA >10 subgroup
Number of subjects: 0
Study 28412590 — intervention group
Group type: COMPARATOR
Intervention: Ramucirumab vs. placebo for CEA ≤10 subgroup
Number of subjects: 0
Study 28412590 — intervention group
Group type: COMPARATOR
Intervention: Ramucirumab vs. placebo for CEA >10 subgroup
Number of subjects: 0
Study 28412590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab treatment
Number of subjects: 0
Study 25468160 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid (25 mg daily for 72 weeks)
Number of subjects: 283
Study 25468160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 283
Study 25468160 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic acid
Number of subjects: 283
Study 23245591 — intervention group
Group type: COMPARATOR
Intervention: Meperidine (0.7 mg/kg) with sham patient controlled analgesia (Group M)
Number of subjects: 90
Study 23245591 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 μg/kg with patient-controlled analgesia pump (Group R1)
Number of subjects: 90
Study 23245591 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.8 μg/kg with patient-controlled analgesia pump (Group R2)
Number of subjects: 90
Study 21460373 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (INH)
Number of subjects: 0
Study 21460373 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 0
Study 21460373 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) combined with Antiretroviral therapy (ART)
Number of subjects: 0
Study 21460373 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid (INH) in children on ART
Number of subjects: 0
Study 19501937 — intervention group
Group type: EXPERIMENTAL
Intervention: diabetes-specific feed
Number of subjects: 25
Study 19501937 — intervention group
Group type: COMPARATOR
Intervention: standard feed
Number of subjects: 25
Study 17522096 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (exercise and manipulation)
Number of subjects: 1334
Study 17522096 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline characteristics (age, work status, age of leaving school, pain and disability, quality of life, beliefs)
Number of subjects: 1334
Study 17522096 — intervention group
Group type: EXPERIMENTAL
Intervention: Episode length at study entry
Number of subjects: 1334
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic sequence training with inclusion instructions
Number of subjects: 0
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Deterministic sequence training with exclusion instructions
Number of subjects: 0
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic sequence training with inclusion instructions
Number of subjects: 0
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic sequence training with exclusion instructions
Number of subjects: 0
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial‐by‐trial generation test under inclusion conditions after longer training
Number of subjects: 0
Study 14979810 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial‐by‐trial generation test under exclusion conditions after longer training
Number of subjects: 0
Study 11820689 — intervention group
Group type: EXPERIMENTAL
Intervention: Crank rate of 70 rev x min(‐1)
Number of subjects: 20
Study 11820689 — intervention group
Group type: EXPERIMENTAL
Intervention: Crank rate of 80 rev x min(‐1)
Number of subjects: 20
Study 9543282 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. corticosteroids
Number of subjects: 0
Study 9543282 — intervention group
Group type: EXPERIMENTAL
Intervention: inhaled corticosteroids
Number of subjects: 0
Study 9543282 — intervention group
Group type: EXPERIMENTAL
Intervention: oral corticosteroids
Number of subjects: 0
Study 9543282 — intervention group
Group type: COMPARATOR
Intervention: untreated asthmatics
Number of subjects: 0
Study 8297217 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg IV DMT
Number of subjects: 12
Study 8297217 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg IV DMT
Number of subjects: 12
Study 8297217 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg IV DMT
Number of subjects: 12
Study 8297217 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg IV DMT
Number of subjects: 12
Study 8297217 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 12
Study 2690660 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (1.0 ml of 100% alcohol/kg body weight)
Number of subjects: 36
Study 2690660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 2690660 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 4357135 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate 400 mug daily
Number of subjects: 10
Study 4357135 — intervention group
Group type: COMPARATOR
Intervention: Freon propellant alone (Control)
Number of subjects: 10
Study 30799167 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary intervention consisting of an educational program and a care program for managing neuropsychiatric symptoms (NPS).
Number of subjects: 274
Study 30799167 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 274
Study 26764132 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional dental education intervention (5 sessions)
Number of subjects: 206
Study 26764132 — intervention group
Group type: COMPARATOR
Intervention: Conventional dental instruction (1 session)
Number of subjects: 206
Study 26294143 — intervention group
Group type: EXPERIMENTAL
Intervention: BPS group (Bacterial Pneumonia Score >4 points)
Number of subjects: 65
Study 26294143 — intervention group
Group type: COMPARATOR
Intervention: Control group (antibiotics at physician's discretion)
Number of subjects: 65
Study 26294143 — intervention group
Group type: EXPERIMENTAL
Intervention: BPS group
Number of subjects: 65
Study 26294143 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 23143901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 260
Study 23143901 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir
Number of subjects: 260
Study 23143901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Oseltamivir)
Number of subjects: 260
Study 23143901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Zanamivir)
Number of subjects: 260
Study 23143901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Oseltamivir and Zanamivir
Number of subjects: 260
Study 22125922 — intervention group
Group type: EXPERIMENTAL
Intervention: Project ALERT (intervention group)
Number of subjects: 34
Study 22125922 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 19111959 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified AED
Number of subjects: 92
Study 19111959 — intervention group
Group type: COMPARATOR
Intervention: Old AED
Number of subjects: 92
Study 17727576 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural modification (moderation of fluid intake or timing of taking anti-diuretic medication)
Number of subjects: 0
Study 17727576 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimuscarinic agents or desmopressin (a nona-peptide analogue of anti-diuretic hormone)
Number of subjects: 0
Study 12880709 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG assessment during 45 s trunk extension at 80% of maximal voluntary contraction torque
Number of subjects: 57
Study 12880709 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG spectral variables and torque
Number of subjects: 57
Study 12880709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ability to fatigue lumbar muscles during contraction
Number of subjects: 57
Study 12880709 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction torque and initial median frequency at L5
Number of subjects: 57
Study 12880709 — intervention group
Group type: EXPERIMENTAL
Intervention: Back muscle training focused on increasing strength and self-efficacy
Number of subjects: 57
Study 10867212 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin-induced extracorporeal LDL/fibrinogen precipitation (HELP)
Number of subjects: 141
Study 9100583 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroxine dose changes
Number of subjects: 9
Study 7691426 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin 1 million KIU (200,000 KIU bolus followed by 100,000 KIU/hr infusion for 8 hours)
Number of subjects: 41
Study 7691426 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 41
Study 3465586 — intervention group
Group type: EXPERIMENTAL
Intervention: Almitrine bismesylate
Number of subjects: 16
Study 3465586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30368347 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Pilates (SP)
Number of subjects: 47
Study 30368347 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension-based (EB) exercises
Number of subjects: 47
Study 30368347 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study 27358418 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate iron (I) group
Number of subjects: 100
Study 27358418 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed iron (D) group
Number of subjects: 100
Study 27358418 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 100
Study 25552609 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise once per week
Number of subjects: 45